Blockbuster, BioSante, Fortune Brands, Hyatt Hotels: United States Equity Preview

Shares of the following companies may have unusual movements in U.S. trading on 15 November. Stock symbols are in parentheses.

Aastrom Biosciences Inc. (ASTM U.S.): The developer of treatments for human tissue repair using stem cells said Atek Medical LLC granted exclusive rights to manufacture products of the cellular carrier deck. Aastrom also presented the plans of the Securities and Exchange Commission to sell up to $ 75 million in securities.

Accelrys Inc. (ACCL U.S.): The maker of molecular modeling software, said it will buy up to $ 6 billion in stock on 31 March.

BioSante Pharmaceuticals Inc. (BPAX U.S.): The developer of hormone replacement products reported a third quarter loss of 16 cents per share, 19 percent higher than the average of two analyst estimates.

Blockbuster Inc. (BLOAQ U.S.): The operation of video rental retailer in Chapter 11 bankruptcy reported its loss in the third quarter fell to 53.5 million U.S. dollars from 114.1 million U.S. dollars last year. Sales fell 19 percent to 736.6 million U.S. dollars.

Fortune Brands Inc. (for U.S.): The maker of Titleist golf balls, Moen faucets and Jim Beam bourbon can work on a plan to break with the investor Bill Ackman Pershing Square Capital Management LP, the Wall Street Journal.

Hyatt Hotels Corp. (H U.S.): The Pritzker family hotel chain which raised 1.09 billion U.S. dollars in an initial public offering last year was a new "buy" at Buckingham Research analyst for equity McKnight Cameron. The 12-month price target is $ 48.

Naugatuck Valley Financial Corp. (NVSL USA) and Southern Connecticut Bancorp (SSE U.S.): The two banks headquartered in Connecticut mutually agreed to terminate their merger agreement, according to a joint statement. The companies said they could not obtain regulatory approval.